As of 2025-12-17, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is 6.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.62 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is 148.3%.
The range of the Relative Valuation is 5.68 - 7.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 18.7x | 17.1x |
| Forward P/E multiples | 15.3x - 21.1x | 17.4x |
| Fair Price | 5.68 - 7.96 | 6.50 |
| Upside | 116.8% - 203.7% | 148.3% |
| Date | P/E |
| 2025-12-15 | 7.28 |
| 2025-12-12 | 7.40 |
| 2025-12-11 | 7.32 |
| 2025-12-10 | 7.08 |
| 2025-12-09 | 7.19 |
| 2025-12-08 | 7.29 |
| 2025-12-05 | 7.08 |
| 2025-12-04 | 7.19 |
| 2025-12-03 | 7.13 |
| 2025-12-02 | 9.15 |
| 2025-12-01 | 10.00 |
| 2025-11-28 | 10.13 |
| 2025-11-26 | 10.02 |
| 2025-11-25 | 10.26 |
| 2025-11-24 | 10.21 |
| 2025-11-21 | 10.08 |
| 2025-11-20 | 10.10 |
| 2025-11-19 | 10.32 |
| 2025-11-18 | 10.53 |
| 2025-11-17 | 10.63 |
| 2025-11-14 | 10.63 |
| 2025-11-13 | 11.91 |
| 2025-11-12 | 12.91 |
| 2025-11-11 | 12.25 |
| 2025-11-10 | 11.56 |
| 2025-11-07 | 10.32 |
| 2025-11-06 | 10.55 |
| 2025-11-05 | 10.26 |
| 2025-11-04 | 9.60 |
| 2025-11-03 | 10.47 |
| 2025-10-31 | 10.26 |
| 2025-10-30 | 10.13 |
| 2025-10-29 | 10.13 |
| 2025-10-28 | 10.32 |
| 2025-10-27 | 10.47 |
| 2025-10-24 | 10.42 |
| 2025-10-23 | 10.29 |
| 2025-10-22 | 9.97 |
| 2025-10-21 | 10.50 |
| 2025-10-20 | 10.90 |
| 2025-10-17 | 10.63 |
| 2025-10-16 | 11.08 |
| 2025-10-15 | 11.01 |
| 2025-10-14 | 9.97 |
| 2025-10-13 | 10.08 |
| 2025-10-10 | 10.85 |
| 2025-10-09 | 11.46 |
| 2025-10-08 | 10.58 |
| 2025-10-07 | 10.37 |
| 2025-10-06 | 10.40 |